Table 2 Perioperative and pathological features in primary or recurrent ovarian cancer patients with ureteral reconstruction
Variables | Total | Primary | Recurrent |
|---|---|---|---|
N = 56 (%) | N = 35 (62.5%) | N = 21 (37.5%) | |
Indications for Ureteral surgery | |||
Ureterovesical invasion by tumor | 52 (92.9) | 32 (91.4) | 20 (95.2) |
Intraoperative injury | 4 (7.1) | 3 (8.6) | 1 (4.8) |
Size of tumor at the ureterovesical area | |||
< 1 cm | 13 (23.2) | 7 (20.0) | 6 (28.6) |
≥ 1 cm | 43 (76.8) | 28 (80.0) | 15 (71.4) |
Residual tumor | |||
Microscopic | 47 (83.9) | 29 (82.9) | 18 (85.7) |
< 1 cm | 9 (16.1) | 6 (17.1) | 3 (14.3) |
≥ 1 cm | 0 (0) | 0 (0) | 0 (0) |
Presence of endometriosis | |||
No | 45 (80.4) | 26 (74.3) | 8 (38.1) |
Yes | 11 (19.6) | 9 (25.8) | 2 (9.5) |
Accompanied surgical procedures | |||
Hysterectomy | 30 (53.6) | 29 (82.9) | 1 (4.8) |
Bilateral salpingo-oophorectomy | 32 (57.1) | 30 (85.7) | 2 (9.5) |
Pelvic Lymphadenectomy | 40 (71.4) | 33 (94.3) | 7 (33.3) |
Para-aortic Lymphadenectomy | 40 (71.4) | 33 (94.3) | 7 (33.3) |
Omentectomy | 40 (71.4) | 29 (82.9) | 11 (52.4) |
Splenectomy | 10 (28.6) | 5 (14.3) | 5 (23.8) |
Rectosigmoid resection | 40 (71.4) | 28 (80.0) | 12 (57.1) |
Ileostomy | 5 (8.9) | 4 (11.4) | 1 (4.8) |
Small bowel resection | 13 (23.2) | 6 (17.1) | 7 (33.3) |
HIPEC | 5 (8.9) | 5 (14.3) | 0 (0) |
Types of Ureteral surgery | |||
Ureteroneocystostomy—Direct reimplantation | 29 (51.8) | 19 (54.3) | 10 (47.6) |
Ureteroneocystostomy—Psoas hitch | 5 (8.9) | 2 (5.7) | 3 (14.3) |
Transureteroureterostomy | 4 (7.1) | 2 (5.7) | 2 (9.5) |
Ureteroureterostomy | 18 (32.1) | 12 (34.3) | 6 (28.6) |
GFR outcome, mL/min/1.73m2; mean | |||
Pre-Op GFR (MDRD) | 77.9 | 80.7 | 73.4 |
Post-Op GFR (MDRD) | 89.1 | 88.9 | 89.5 |
% Changes | 14.3 | 10.2 | 21.9 |
Operation time, hours; median (min–max) | 7 (3–12) | 6 (3–12) | 5 (4–10) |
Blood loss, mL; median (min–max) | 800 (200–5700) | 500 (300–5700) | 500 (200–1600) |
Interval from operation to adjuvant chemotherapy (days); median (min–max) (missing = 4) | 24 (10–62) | 24 (11–40) | 27 (10–62) |
Day of stent removal; median (min–max) | 40 (13–322) | 43 (13–241) | 29 (21–322) |
Hospital stays, days; median (min–max) | 22 (5–63) | 24 (9–63) | 19 (10–63) |
Perioperative RBC transfusion, unit; median (min–max) | 1 (0–9) | 2 (0–9) | 0.5 (0–5) |
Antibiotics use, days; median (min–max) | 6 (2–59) | 10 (2–59) | 3 (2–25) |